These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20306832)

  • 1. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
    Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G
    Semin Diagn Pathol; 2010 Feb; 27(1):69-76. PubMed ID: 20306832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine Tumors of the Breast.
    Rosen LE; Gattuso P
    Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
    Kelten Talu C; Savli TC; Huq GE; Leblebici C
    Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
    Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary breast carcinomas with neuroendocrine features: Clinicopathological features and analysis of tumor growth patterns in 36 cases.
    Kelten Talu C; Leblebici C; Kilicaslan Ozturk T; Hacihasanoglu E; Baykal Koca S; Gucin Z
    Ann Diagn Pathol; 2018 Jun; 34():122-130. PubMed ID: 29661717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome.
    Bogina G; Munari E; Brunelli M; Bortesi L; Marconi M; Sommaggio M; Lunardi G; Gori S; Massocco A; Pegoraro MC; Zamboni G
    Histopathology; 2016 Feb; 68(3):422-32. PubMed ID: 26114478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine breast carcinoma: a rare but challenging entity.
    Trevisi E; La Salvia A; Daniele L; Brizzi MP; De Rosa G; Scagliotti GV; Di Maio M
    Med Oncol; 2020 Jul; 37(8):70. PubMed ID: 32712767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.
    Weigelt B; Geyer FC; Horlings HM; Kreike B; Halfwerk H; Reis-Filho JS
    Mod Pathol; 2009 Nov; 22(11):1401-14. PubMed ID: 19633645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
    Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A morphological and immunohistochemical study of ductal carcinoma in situ, invasive breast carcinoma of no special type, and mucinous carcinoma of the breast in comparison with solid papillary carcinoma regarding neuroendocrine marker expression.
    Otsuki Y; Asano Y; Ikeya T; Ishida Y; Sezaki S; Kobayashi H
    Virchows Arch; 2024 Sep; 485(3):547-555. PubMed ID: 38958708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of multicentric low-grade neuroendocrine breast tumor with an unusual histological pattern.
    D'Antonio A; Addesso M; Memoli D; Cascone A; Cremone L
    Breast Dis; 2016; 36(4):161-164. PubMed ID: 27802189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma.
    Wachter DL; Hartmann A; Beckmann MW; Fasching PA; Hein A; Bayer CM; Agaimy A
    Biomed Res Int; 2014; 2014():408459. PubMed ID: 24701575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucinous carcinoma of the breast: a comparative study on cytohistological findings associated with neuroendocrine differentiation.
    Ohashi R; Sakatani T; Matsubara M; Watarai Y; Yanagihara K; Yamashita K; Tsuchiya S; Takei H; Naito Z
    Cytopathology; 2016 Jun; 27(3):193-200. PubMed ID: 26804749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary and neuroendocrine breast lesions: the WHO stance.
    Tan PH; Schnitt SJ; van de Vijver MJ; Ellis IO; Lakhani SR
    Histopathology; 2015 May; 66(6):761-70. PubMed ID: 24845113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
    Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
    J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters.
    Tse GM; Ma TK; Chu WC; Lam WW; Poon CS; Chan WC
    Mod Pathol; 2004 May; 17(5):568-72. PubMed ID: 15001999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
    Tang F; Wei B; Tian Z; Gilcrease MZ; Huo L; Albarracin CT; Resetkova E; Zhang H; Sahin A; Chen J; Bu H; Abraham S; Wu Y
    Histopathology; 2011 Jul; 59(1):106-15. PubMed ID: 21668471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.
    Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P
    Oncology; 2019; 96(3):147-155. PubMed ID: 30282082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast: a case report and hypothesis of neuroendocrine tumor development.
    Miura K; Nasu H; Ogura H
    Pathol Int; 2012 May; 62(5):331-4. PubMed ID: 22524661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.